Home Faculty IQ Test Crossword Podcast Whiteboards

RA Quality Measures

Podcast

Podcast

Please answer the demographic questions and review the CME Information

Peer-to-Peer Dialogue CME

New and Emerging Treatment Options

Statement of Need
Documentation and reporting of quality measures have become an integral part of medical practice. There are assessment and management PQRS measures for the care of patients with rheumatoid arthritis. Data on these measures can provide insight into the rheumatology practice but many providers do not receive feedback on their reported measures. Together with recent ACR practice recommendations, analysis of quality data can help enhance the care of patients with RA.
 
Target Audience
This course is designed to meet the educational needs of rheumatologists.

Educational Objective(s)

  • Formulate a plan for improving key aspects of care being provided to patients with RA

Course Description
This activity is comprised of a brief overview of the quality measures in Rheumatology.

Accreditation Statement
Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty
Kenneth S. Saag, MD, MSc
Professor of Medicine, Division of Clinical Immunology and Rheumatology
University of Alabama at Birmingham (UAB) School of Medicine
Professor of Epidemiology
UAB School of Public Health
Birmingham, Alabama

Vibeke Strand, MD, MACR, FACP
Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Portola Valley, California


Disclosure of Potential Conflicts of Interest
It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter’s content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.

While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
In accordance with the policy of Cedars-Sinai, faculty are asked to disclose any affiliation or financial interest that may affect the content of their presentations.

The faculty reported the following:

Name of Individual

Individual’s Role in Activity

Name of Commercial Interest

Nature of Relationship

Kenneth S. Saag, MD, MSc

Faculty

Abbott, Amgen, Ardea/AstraZeneca, BMS, Lilly, Merck, Pfizer, Roche/Genentech

Consulting fee

Vibeke Strand, MD, MACR, FACP

Faculty

Abbvie, Afferent, Alder, Amgen Corporation, Anthera, AstraZeneca, aTyr, BiogenIdec, Biotest, Bioventus, BMS,
Boehringer Ingelheim, Carbylan, Celgene, Celltrion, CORRONA, Crescendo/Myriad Genetics, Daiichi Sankyo, EMD Serono, Eupraxia, Genentech/Roche, GlaxoSmithKline, Iroko, Janssen, Jazz Pharmaceuticals, Kypha, Lilly, Novartis, Pfizer, Protagen, Regeneron, Sandoz, Sanofi, SKK, UCB, Vertex

Abbvie, Amgen, BiogenIdec, BMS, Carbylan, Crescendo, Genentech/Roche, GlaxoSmithKline, Iroko, Janssen, Jazz, Lilly, MerckSerono, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, UCB

Consulting fee

 

 

 

 

 

 

Advisory Board

The independent reviewer and following planners had no relevant conflicts of interest to report: Michael Weisman, MD, Ani Mardakhanian, MHA, Megan Swartz, Daniel Rabin, PhD, Heather Tarbox, MPH, Amanda Noe.

Commercial Support Acknowledgment
This activity is supported by an educational grant from Pfizer, Inc.

Date of Release/Expiration
The enduring material will be available from March 31, 2016–March 30, 2017.

Estimated Time to Complete
The activity consists of one, ten-minute session.

Contact Information
Please send all inquiries to:

Kelley Johnson
Project Coordinator
The France Foundation
kjohnson@francefoundation.com

© 2016 Cedars-Sinai Medical Center. All rights reserved.

Please agree to continue.